Exploring the link between diabetes duration and cardiovascular disease in patients with type 2 diabetes

Methavee Poochanasri1, Chutawat Kookanok2, Ram Rangsin3,4

  • 1Department of Medicine, Bhumibol Adulyadej Hospital, Bangkok, 10220, Thailand.

Scientific Reports
|June 16, 2026
PubMed

Insights

Longer diabetes duration in Type 2 Diabetes Mellitus (T2DM) patients is linked to increased risks of coronary artery disease (CAD), congestive heart failure (CHF), and peripheral arterial disease (PAD). This association highlights the importance of managing diabetes duration for cardiovascular health.

Area of Science:

  • Endocrinology
  • Cardiology
  • Public Health

Background:

  • Type 2 Diabetes Mellitus (T2DM) is a significant risk factor for cardiovascular disease (CVD).
  • Understanding the impact of diabetes duration on specific cardiovascular outcomes is crucial for patient management.

Purpose of the Study:

  • To investigate the association between the duration of T2DM and major cardiovascular outcomes (CAD, CHF, CVA, PAD) in Thai adults.
  • To identify specific cardiovascular risks associated with different durations of diabetes.

Main Methods:

  • Cross-sectional study using nationwide data from Thailand (2018).
  • Included 34,131 adult T2DM patients, stratified by diabetes duration (<5, 5-9, 10-14, ≥15 years).
  • Multivariable logistic regression adjusted for demographic and clinical factors.

Main Results:

  • Longer diabetes duration (≥15 years) was associated with significantly higher odds of CAD (AOR 1.80), CHF (AOR 2.34), and PAD (AOR 6.47) compared to <5 years.
  • No significant association was found between diabetes duration and cerebrovascular accident (CVA).
  • Prevalence rates: CAD 1.9%, CHF 0.8%, CVA 1.5%, PAD 0.3%.

Conclusions:

  • A longer duration of T2DM is cross-sectionally associated with an increased prevalence of CAD, CHF, and PAD.
  • These findings underscore the cumulative impact of diabetes duration on cardiovascular complications.
  • Further longitudinal research is recommended to establish causality and inform clinical interventions.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...